PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15927312

[Toxocara canis encephalitis: case report].

R Mrissa·R Battikh·N Ben Abdelhafidh·B Jemli·O Azzouz·J Zaouali·B Louzir·F M'sadek·N Ben Abdallah·S Gargouri·M Yedeas·S Othmani
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

AlbendazoleAnimalsAnthelminticsAnti-Inflammatory AgentsDrug Therapy, CombinationEncephalitisFollow-Up StudiesHumansMaleMiddle AgedPrednisoneTime FactorsToxocara canisToxocariasisTreatment OutcomeCase ReportsLetter

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Mrissa, R Battikh, N Ben Abdelhafidh, B Jemli, O Azzouz, J Zaouali, B Louzir, F M'sadek, N Ben Abdallah, S Gargouri, M Yedeas, S Othmani. 2005. [Toxocara canis encephalitis: case report].. https://doi.org/10.1016/j.revmed.2005.04.025

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

[Ocular toxocariasis. From biology to therapy].

Ocular toxocariasis represents an organ manifestation of the systemic infection with the Nematode larva Toxocara canis. The infection can provoke very different changes in the eye. Especially posterior uveitis, vitreous body infiltrates, epiretinal membranes and suberetinal granulomas can occur. The diagnosis of these changes can be difficult due to the variety of the symptoms and on the other side by the absence of characteristic specific changes. Moreover unclear findings can occur when only serological examinations are performed. In unclear cases the antibody-detection by means of ELISA from the vitreous body fluid can be useful. The examination of vitreous body material can prove toxocara infection when no systemic signs of infection are present and no antibodies are detectable in the serum. Besides the systemic anti-helminthic therapy with Albendazol the pars plana vitrectomy is a substantial therapeutic option in ocular toxocariasis when vitreo-retinal complications are present. A well timed adequate therapy can stabilize the visual acuity in many cases.

Albendazole↗
PubMed2007

Case report: Echinococcus disease of the bone presenting as a femoral shaft nonunion.

Osseous hydatidosis (Echinococcus infection) is a rare parasitic bone infection that poses challenges in diagnosis and treatment. We present a novel case of osseous hydatidosis of the femoral shaft that was diagnosed at the time of surgery for a recalcitrant femoral shaft nonunion. We know of no reports of osseous hydatidosis presenting as a femoral shaft nonunion. A discussion of the challenges in diagnosis and treatment of osseous hydatidosis are discussed, and the literature on osseous hydatidosis is reviewed.

Albendazole↗
PubMed2006

Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry.

The analysis of albendazole sulfoxide, albendazole sulfone, praziquantel and trans-4-hydroxypraziquantel in plasma was carried out by high-performance liquid chromatography-mass spectrometry ((LC-MS-MS). The plasma samples were prepared by liquid-liquid extraction using dichloromethane as extracting solvent. The partial HPLC resolution of drug and metabolites was obtained using a cyanopropyl column and a mobile phase consisting of methanol:water (3:7, v/v) plus 0.5% of acetic acid, at a flow rate of 1.0 mL/min. Multi reaction monitoring detection was performed by electrospray ionization in the positive ion mode, conferring additional selectivity to the method. Method validation showed relative standard deviation (precision) and relative errors (accuracy) lower than 15% for all analytes evaluated. The quantification limit was 5 ng/mL and the linear range was 5-2500 ng/mL for all analytes. The method was used for the determination of drug and metabolites in swine plasma samples and proved to be suitable for pharmacokinetic studies.

Albendazole↗